Clinical Trials Directory

Trials / Completed

CompletedNCT04837898

Haskap and Endurance Running Performance

The Influence of Haskap Berry on Exercise Performance

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Northumbria University · Academic / Other
Sex
Male
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

This study will employ a randomised, double-blind, placebo-controlled, independent groups experimental design. Submaximal, maximal and 5 km time trial running performance will be assessed before and after supplementation with haskap berry or a placebo.

Detailed description

Participants will consume haskap berry powder or an isocaloric placebo for 7 days. They will be required to run on a treadmill before and after supplementation to asses the influence on the intervention on aerobic performance parameters. Other performance parameters such as blood lactate, heart rate, ratings of perceived exertion and respiratory variables will also be monitored throughout the various elements of the exercise trials.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTHaskapaHaskapa Ltd, Oxford, UK
DIETARY_SUPPLEMENTPlaceboisocaloric to the haskap powder

Timeline

Start date
2021-04-12
Primary completion
2021-11-08
Completion
2021-12-08
First posted
2021-04-08
Last updated
2022-04-13

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT04837898. Inclusion in this directory is not an endorsement.